Terms: = Leukemia AND KLF6, RP11-184A2_1, 1316, ENSG00000067082, ST12, DKFZp686N0199, CPBP, Zf9, COPEB, ZF9, PAC1, GBF, BCD1 AND Treatment
29866 results:
1. Impact of Fee For Service on the Efficiency and Survival of Seguro Popular's Patients With Acute Lymphoblastic leukemia in Mexico.
Cerecero-García D; Macías-González F; Muñoz-Aguirre P; Huerta-Gutierrez R; Zapata M; Rivera-Luna R; Lajous M; Bautista-Arredondo S
JCO Glob Oncol; 2024 May; 10():e2300060. PubMed ID: 38754053
[TBL] [Abstract] [Full Text] [Related]
2. Pharmacogenomics, Race, and treatment Outcome in Pediatric Acute Myeloid leukemia.
Lamba JK; Marrero R; Wu H; Cao X; Parcha PK; Karol SE; Inaba H; Kuo DJ; Degar BA; Heym K; Taub JW; Lacayo NJ; Pui CH; Ribeiro RC; Pounds SB; Rubnitz JE
JAMA Netw Open; 2024 May; 7(5):e2411726. PubMed ID: 38753328
[TBL] [Abstract] [Full Text] [Related]
3. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
[TBL] [Abstract] [Full Text] [Related]
4. Phytochemical study of
Moraes ARA; Siqueira EP; Kohlhoff M; Evangelista FCG; Sabino AP; Vieira Filho SA; Alcântara AFC; Duarte LP; Sousa GF
Nat Prod Res; 2024 Jun; 38(11):1956-1960. PubMed ID: 38739565
[No Abstract] [Full Text] [Related]
5. Effective delivery of anti-PD-L1 siRNA with human heavy chain ferritin (HFn) in acute myeloid leukemia cell lines.
Rajabinejad M; Valadan R; Tehrani M; Najafi A; Negarandeh R; Saeedi M; Asgarian-Omran H
Med Oncol; 2024 May; 41(6):149. PubMed ID: 38739199
[TBL] [Abstract] [Full Text] [Related]
6. TurboID-Based IRE1 Interactome Reveals Participants of the Endoplasmic Reticulum-Associated Protein Degradation Machinery in the Human Mast Cell leukemia Cell Line HMC-1.2.
Ahmed N; Preisinger C; Wilhelm T; Huber M
Cells; 2024 Apr; 13(9):. PubMed ID: 38727283
[TBL] [Abstract] [Full Text] [Related]
7. Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation.
Gregorio C; Spreafico M; D'Amico S; Sauta E; Asti G; Lanino L; Tentori CA; Platzbecker U; Haferlach T; Diez-Campelo M; Fenaux P; Komrokji R; Della Porta MG; Ieva F
JCO Clin Cancer Inform; 2024 May; 8():e2300205. PubMed ID: 38723213
[TBL] [Abstract] [Full Text] [Related]
8. Systematic analysis of mucosal-associated invariant T cells in haematological malignancies.
Bacova B; Cierny J; Nemcekova L; Smetanova/Brozova J; Novak J
Scand J Immunol; 2024 Jun; 99(6):e13364. PubMed ID: 38720521
[TBL] [Abstract] [Full Text] [Related]
9. Regulation of cytokine and chemokine expression by histone lysine methyltransferase MLL1 in rheumatoid arthritis synovial fibroblasts.
Okamoto K; Araki Y; Aizaki Y; Tanaka S; Kadono Y; Mimura T
Sci Rep; 2024 May; 14(1):10610. PubMed ID: 38719857
[TBL] [Abstract] [Full Text] [Related]
10. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
[No Abstract] [Full Text] [Related]
11. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
[No Abstract] [Full Text] [Related]
12. [treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].
Zhang XS; Liu BC; Du X; Zhang YL; Xu N; Liu XL; Li WM; Lin H; Liang R; Chen CY; Huang J; Yang YF; Zhu HL; Pan L; Wang XD; Li GH; Liu ZG; Zhang YQ; Liu ZF; Hu JD; Liu CS; Li F; Yang W; Meng L; Han YQ; Lin LE; Zhao ZY; Tu CQ; Zheng CF; Bai YL; Zhou ZP; Chen SN; Qiu HY; Yang LJ; Sun XL; Sun H; Zhou L; Liu ZL; Wang DY; Guo JX; Pang LP; Zeng QS; Suo XH; Zhang WH; Zheng YJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):215-224. PubMed ID: 38716592
[No Abstract] [Full Text] [Related]
13. A pharmacodynamic assay to monitor treatment with the hypomethylating cytosine analogs, decitabine and azacitidine.
Jacobberger JW; Woost PG
Methods Cell Biol; 2024; 186():131-150. PubMed ID: 38705597
[TBL] [Abstract] [Full Text] [Related]
14. Determination of drug-related problems in the hematology service: a prospective interventional study.
Albayrak A; Özbalcı D
BMC Cancer; 2024 May; 24(1):552. PubMed ID: 38698336
[TBL] [Abstract] [Full Text] [Related]
15. On the mechanism of wogonin against acute monocytic leukemia using network pharmacology and experimental validation.
Wang X; Wang Y; Chen J; Wang Q; Liu Z; Yin Y; Yang T; Shen T; Sa Y
Sci Rep; 2024 May; 14(1):10114. PubMed ID: 38698063
[TBL] [Abstract] [Full Text] [Related]
16. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial.
Burris HA; Okusaka T; Vogel A; Lee MA; Takahashi H; Breder V; Blanc JF; Li J; Bachini M; Żotkiewicz M; Abraham J; Patel N; Wang J; Ali M; Rokutanda N; Cohen G; Oh DY
Lancet Oncol; 2024 May; 25(5):626-635. PubMed ID: 38697156
[TBL] [Abstract] [Full Text] [Related]
17. Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment.
Bhattarai KR; Mobley RJ; Barnett KR; Ferguson DC; Hansen BS; Diedrich JD; Bergeron BP; Yoshimura S; Yang W; Crews KR; Manring CS; Jabbour E; Paietta E; Litzow MR; Kornblau SM; Stock W; Inaba H; Jeha S; Pui CH; Cheng C; Pruett-Miller SM; Relling MV; Yang JJ; Evans WE; Savic D
Nat Commun; 2024 May; 15(1):3681. PubMed ID: 38693155
[TBL] [Abstract] [Full Text] [Related]
18. Testing an Intervention to Improve Health Care Worker Well-Being During the COVID-19 Pandemic: A Cluster Randomized Clinical Trial.
Meredith LS; Ahluwalia S; Chen PG; Dong L; Farmer CM; Bouskill KE; Dalton S; Qureshi N; Blagg T; Timmins G; Schulson LB; Huilgol SS; Han B; Williamson S; Watson P; Schnurr PP; Martineau M; Davis K; Cassells A; Tobin JN; Gidengil C
JAMA Netw Open; 2024 Apr; 7(4):e244192. PubMed ID: 38687482
[TBL] [Abstract] [Full Text] [Related]
19. In vitro anti-leukemic effect of Wharton's jelly derived mesenchymal stem cells.
Süleymanoğlu M; Erol Bozkurt A; Abatay Sel F; Özdemir İA; Savran Oğuz F; Kuruca DS; Aktaş Z; Karakaş Z; Öncül MO
Mol Biol Rep; 2024 Apr; 51(1):595. PubMed ID: 38683436
[TBL] [Abstract] [Full Text] [Related]
20. Assessment of the
Nasr GM; Thawabieh OM; Talaat RM; Moawad M; El Hamshary MO
Front Biosci (Landmark Ed); 2024 Apr; 29(4):162. PubMed ID: 38682177
[TBL] [Abstract] [Full Text] [Related]
[Next]
